You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Investigational Drug Information for BAY2433334


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for BAY2433334?

BAY2433334 is an investigational drug.

There have been 7 clinical trials for BAY2433334. The most recent clinical trial was a Phase 2 trial, which was initiated on December 15th 2022.

The most common disease conditions in clinical trials are Atrial Fibrillation, Stroke, and Ischemic Stroke. The leading clinical trial sponsors are Bayer, Population Health Research Institute, and [disabled in preview].

Recent Clinical Trials for BAY2433334
TitleSponsorPhase
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled tBayerPhase 3
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for StrokeBayerPhase 3
A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With NoBayerPhase 1

See all BAY2433334 clinical trials

Clinical Trial Summary for BAY2433334

Top disease conditions for BAY2433334
Top clinical trial sponsors for BAY2433334

See all BAY2433334 clinical trials

International Patents for BAY2433334

Drugname Country Document Number Estimated Expiration Related US Patent
BAY2433334 Argentina AR105294 2035-07-09 ⤷  Sign Up
BAY2433334 Australia AU2016289746 2035-07-09 ⤷  Sign Up
BAY2433334 Brazil BR112018000209 2035-07-09 ⤷  Sign Up
BAY2433334 Canada CA2990901 2035-07-09 ⤷  Sign Up
BAY2433334 Chile CL2018000039 2035-07-09 ⤷  Sign Up
BAY2433334 China CN108026072 2035-07-09 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.